[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  FloatRaider [@FLOATRAIDER](/creator/twitter/FLOATRAIDER) on x XX followers Created: 2025-07-14 14:15:02 UTC GLMD has been consolidating between $1.95–$1.99 —a textbook pause ahead of the July XX definitive licensing agreement. With oral sublingual semaglutide targeting emerging GLP‑1 markets, brace for a potential breakout. #biotech #stocks $KWE $NRBO $RXDX $BBIG $GME $GEVO $IBIO $HKD XXX engagements  **Related Topics** [hong kong dollar](/topic/hong-kong-dollar) [gme](/topic/gme) [stocks](/topic/stocks) [$hkd](/topic/$hkd) [$ibio](/topic/$ibio) [$gevo](/topic/$gevo) [$bbig](/topic/$bbig) [$nrbo](/topic/$nrbo) [Post Link](https://x.com/FLOATRAIDER/status/1944762567676641392)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FloatRaider @FLOATRAIDER on x XX followers
Created: 2025-07-14 14:15:02 UTC
GLMD has been consolidating between $1.95–$1.99 —a textbook pause ahead of the July XX definitive licensing agreement. With oral sublingual semaglutide targeting emerging GLP‑1 markets, brace for a potential breakout. #biotech #stocks $KWE $NRBO $RXDX $BBIG $GME $GEVO $IBIO $HKD
XXX engagements
Related Topics hong kong dollar gme stocks $hkd $ibio $gevo $bbig $nrbo
/post/tweet::1944762567676641392